Brooks Rahmer
Contatto Relazioni con gli Investitori presso ROCKET PHARMACEUTICALS, INC.
Posizioni attive di Brooks Rahmer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | - | - |
Storia della carriera di Brooks Rahmer
Precedenti posizioni note di Brooks Rahmer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MYOKARDIA, INC. | Contatto Relazioni con gli Investitori | 01/05/2019 | 01/01/2021 |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Investor Relations Contact | 2 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Brooks Rahmer
- Esperienza
